Soleno TherapeuticsSLNO
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$40.80avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Soleno Therapeutics Inc. (SLNO) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was TCG Crossover Management, LLC ($22.4M).
- Company
- Soleno Therapeutics Inc.
- CUSIP
- 834203200
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| TCG Crossover Management, LLC | 2.34% | No change | 550,000 | $22.4M |
"% of holder's portfolio" is SLNO's weight in each manager's 13F, not the share of Soleno Therapeutics Inc. the manager owns.